T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens
- 1 July 1993
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 36 (4) , 223-228
- https://doi.org/10.1007/bf01740903
Abstract
The bacterial superantigen staphylococcal enterotoxin A (SEA) induces T cell activation as well as directing activated T cells to kill major-histocompatibilitycomplex-class-II-expressing tumours such as freshly prepared leukemia cells. We now report that conjugates of SEA and the colon-carcinoma-reactive mAb C215 mediate T-cell-dependent killing of freshly isolated cells obtained from surgical specimens of human colon carcinomas. Cytotoxicity was observed at nanomolar concentrations of conjugate while no or very low effects were seen with the mAb C215 or SEA alone. Tumour-infiltrating lymphocytes (TIL) did not exert any cytotoxicity against conjugate-treated tumour cells immediately after isolation. In vitro culture of TIL with interleukin-2 and SEA resulted in SEA-mAb-conjugate-dependent killing of freshly isolated tumour cells. This suggests that mAb-SEA conjugates may be of potential use to target T lymphocytes, including TIL, against colon carcinoma cells in vivo.Keywords
This publication has 33 references indexed in Scilit:
- Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells.The Journal of Experimental Medicine, 1992
- Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin ACancer Immunology, Immunotherapy, 1991
- Human major histocompatibility complex class II‐negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptorEuropean Journal of Immunology, 1991
- Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrenceInternational Journal of Cancer, 1991
- The TcR‐CD3 Complex is Required for Activation of Human Lymphocytes with Staphylococcal Enterotoxin AScandinavian Journal of Immunology, 1990
- Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activityInternational Journal of Cancer, 1990
- Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patientsCancer, 1989
- Characterization of activated lymphocytes in colon cancerClinical Immunology and Immunopathology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cellsInternational Journal of Cancer, 1988